Benocyclidine, also known as BTCP, is a psychoactive molecule of the arylcyclohexylamine class, related to phencyclidine (PCP). It acts as a potent and selective dopamine reuptake inhibitor (DRI) and psychostimulant.
Unlike related compounds like PCP and ketamine, benocyclidine is a pure DRI with negligible affinity for the NMDA receptor, lacking anticonvulsant, anesthetic, hallucinogenic, or dissociative effects.
It has been used to label the dopamine transporter and was studied to identify a pharmacophore for DRI-type stimulants.
The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.
| Other Names | BTCP, 1-(1-(benzo[b]thiophen-2-yl)cyclohexyl)piperidine, 1-[1-(1-benzothiophen-2-yl)cyclohexyl]piperidine, Benocyclidine |
|---|---|
| IUPAC Name | 1-[1-(1-benzothiophen-2-yl)cyclohexyl]piperidine |
| CAS | 112726-66-6 |
| Molecular Weight | 299.5 |
| Molecular Formula | C19H25NS |
| SMILES | C1CCC(CC1)(C2=CC3=CC=CC=C3S2)N4CCCCC4 |